Search results
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for ...
Sierra Sun Times· 1 day agoAffordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters via Yahoo Finance· 19 hours agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
Weight Loss Drugs and Medicare: What You Need to Know
TheStreet.com· 22 hours agoMore weight loss drugs have been approved for coverage by Medicare, but what are the challenges potential users face? Medicare has recently approved coverage ...
Michigan’s largest insurer to drop weight-loss drug coverage
Chicago Tribune· 2 days agoWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run...
Making the case for Wegovy coverage: Drug keeps weight off for 4 years, aids heart health
BenefitsPRO· 3 days agoDrugmaker Novo Nordisk has released two new trial results that could strengthen the case for...
Weight loss: Bariatric surgery more effective than obesity drugs
Medical News Today· 3 days agoResearchers say weight loss surgery is the best option for losing and sustaining weight loss. GLP-1...
Weight Loss Drugs: Are They Really Magic?
Motley Fool via Yahoo Finance· 20 hours agoTalking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary Benefits and ...
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters via Yahoo News· 4 days agoEvidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart...
Ozempic for cats and dogs is on its way
Quartz· 22 hours agoWhile humans continue to grapple with shortages of weight loss drugs like Ozempic and Wegovy, their furry friends may soon be in luck ...
Employer coverage for weight-loss drugs rises sharply, survey finds By Reuters
Investing.com· 19 hours agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
